Education
About Us
Working with TipRanks
Follow Us
Andrew Callos Insider Profile
4 Followers
Andrew Callos, EVP & CCO at Cytokinetics, holds 64.43K shares in Cytokinetics (Ticker: CYTK). Most recently, Andrew Callos Sold $3,341 shares of Cytokinetics on Mar 07, 2025 for an estimated value of 144.57K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+0.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
EVP & CCO
Roles that Andrew Callos holds in companies
Most Profitable Insider Trade
The most profitable trade made by Andrew Callos
Andrew Callos's Trading History
List of latest transactions for each holding click on a transaction to see Andrew Callos's performance on stock
You May Also Like
Andrew Callos insider profile FAQ
What is the percentage of profitable transactions made by Andrew Callos?
The percentage of profitable transactions made by Andrew Callos is 50%.
What is the average return per transaction made by Andrew Callos?
The average return per transaction made by Andrew Callos is 0.50%.
What stocks does Andrew Callos hold?
Andrew Callos holds: CYTK stocks.
What was Andrew Callos’s latest transaction?
Andrew Callos latest transaction was an Informative Sell of $144.57K.
What was Andrew Callos's most profitable transaction?
Andrew Callos’s most profitable transaction was an Informative Sell of CYTK stock on March 5, 2025. The return on the trade was 1.00%.
What is Andrew Callos's role in Cytokinetics?
Andrew Callos's role in Cytokinetics is EVP & CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.